Ljubljana, Slovenia

Ales Krbavcic

This inventor holds 1 USPTO granted patent. Top assignees: Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., Univerza V Ljubljani, Fakulteta Za Naravoslovje in Technologijo, Oddelek. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ales Krbavcic. Retrieved from https://idiyas.com/inventor/ales-krbavcic-9rbn0r3y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ales Krbavcic: Innovator in Heterocyclic Acyldipeptides

Introduction

Ales Krbavcic is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on heterocyclic acyldipeptides. His research and inventions have the potential to impact various applications in medicine and chemistry.

Latest Patents

Ales Krbavcic holds a patent for "Heterocyclic acyldipeptides, processes for the preparation thereof." This patent showcases his expertise in developing new compounds that could lead to advancements in therapeutic treatments.

Career Highlights

Throughout his career, Ales has worked with esteemed institutions such as the University of Ljubljana, Faculty of Natural Sciences and Engineering, and Lek, a pharmaceutical and chemical products manufacturer. His experience in these organizations has allowed him to refine his skills and contribute to significant research projects.

Collaborations

Ales has collaborated with notable colleagues, including Gregor Sersa and Srdjan Novakovic. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ales Krbavcic's work in the field of heterocyclic acyldipeptides exemplifies his dedication to advancing pharmaceutical science. His contributions are valuable to the ongoing development of new medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…